Z-1441-2013 Class III Terminated

Recalled by Optovue, Inc. — Fremont, CA

FDA device recall Z-1441-2013 was initiated by Optovue, Inc. on May 14, 2013 and is designated Class III. Reason for recall: Colors from the NDB comparison for Ganglion Cell Complex thickness in the singular OU report in iVue version 3.0 (US) and 3.1(international) are different from those in the individual iWellness ID and… The recall status is terminated (terminated Oct 24, 2013). Affected quantity: ~329 users.

Recall details

Product Type
Devices
Report Date
Jun 12, 2013
Initiation Date
May 14, 2013
Termination Date
Oct 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
~329 users

Product description

Optovue iVue with Normative Database (NDB) with Software Version 3.0 and 3.1. Intended for in vivo imaging.

Reason for recall

Colors from the NDB comparison for Ganglion Cell Complex thickness in the singular OU report in iVue version 3.0 (US) and 3.1(international) are different from those in the individual iWellness ID and OS reports.

Distribution pattern

Distributed Nationwide and in Canada.

Code information

iVue software version 3.0 and 3.1 3.1 is international version, only distributed to Canada but not currently installed in any Canadian facilities.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1441-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1441-2013. Report a data issue: hello@regdatalab.com.